Laura Michaelis

Clinical trials

• Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia

  Principal investigator · Terminated · Phase 4

  Medical College of Wisconsin

  2019–2022
• Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

  Principal investigator · Completed · Phase 2, Phase 3

  National Cancer Institute (NCI)

  2018–2024
• Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

  Study chair · Recruiting

  Center for International Blood and Marrow Transplant Research

  2016–2027
• Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  Site PI · Recruiting · Phase 1, Phase 2

  Disc Medicine, Inc

  2022–2027